Eiji Kojima

Verified email at gmail.com

1295

Scholar Citations

14

Scholar h-index

15

Scholar i10-index

RECENT SCHOLAR PUBLICATIONS

  • Health status predicted mortality in hypercapnic patients with noninvasive ventilation
    T Oga, H Taniguchi, H Kita, T Tsuboi, K Tomii, M Ando, E Kojima, ...
    European Respiratory Journal 46 (suppl 59) 2015

  • Evolving Technologies Strategies Found in Recent Eucalyptus and Acacia Tree Farms Pursuing Intensive Agriculture
    E Kojima
    Japan Tappi Journal 55 (7), 915-929,015 2001

  • Effective delivery of a lipophilic 6-chloro-2', 3'-dideoxyguanosine (6-Cl-ddG) into rat lymphoid tissues
    Y Fujii, H Akari, M Machida, E KOJIMA, K MURAKAMI, Y YOSHIKAWA
    Experimental animals 48 (4), 241-246 1999

  • The result of anti-tumor screening as to 2, 6-diamino-9-(Np-toluenesulfonyl-pyrrolidinyl-2-methyl)-puirine
    E Kojima
    Nucleic Acids Symposium Series, 193-194 1998

  • Antiviral effects of 6-chloro-2', 3'-dideoxyguanosine in rhesus monkeys acutely infected with simian immunodeficiency virus.
    Y Fujii, R Mukai, H Akari, M Machida, K Mori, M Takasaka, E Kojima, ...
    Antiviral chemistry & chemotherapy 9 (1), 85-92 1998

  • Efficacy of 6-chloro-2', 3'-dideoxyguanosine (6-Cl-ddG) on rhesus macaque monkeys chronically infected with simian immunodeficiency virus (SIVmac239)
    Y Fujii, R Mukai, K Mori, H Akari, I Otani, F Ono, E Kojima, M Takasaka, ...
    JAIDS Journal of Acquired Immune Deficiency Syndromes 16 (5), 313-317 1997

  • Identification of Eucalyptus citriodora clones micropropagated in tissue culture.
    E Kojima, M Izumi, T Tanabe, M Matsuda, T Shimizu, A Murakami, ...
    Nucleic Acids Symposium Series, 171-172 1997

  • Biological behaviour of 6-chloro-2', 3'-dideoxyguanosine and 6-chloro-2', 3'-dideoxyinosine in the brains of mice.
    Y Fujii, E Kojima, I Ohtani, R Mukai, K Murakami, Y Yoshikawa
    Nucleic Acids Symposium Series, 173-174 1997

  • Random amplified polymorphic DNA observed in Eucalyptus by PCR study with random primers.
    M Izumi, E Kojima, M Matsuda, T Shimizu, A Murakami, T Tanabe, ...
    Nucleic Acids Symposium Series, 167-168 1997

  • Novel primers designed for microsatellite loci in Eucalyptus and identification by PCR fingerprints.
    M Matsuda, E Kojima, M Izumi, K Murakami
    Nucleic Acids Symposium Series, 169-170 1997

  • Effects of 6-chloro-2', 3'-dideoxyguanosine (6-Cl-ddG) in surface lymph nodes of rhesus monkeys (Macaca mulatta) chronically infected with simian immunodeficiency virus (SIVmac239)
    I OTANI, Y FUJII, H AKARI, R MUKAI, K MORI, F ONO, E KOJIMA, ...
    Journal of veterinary medical science 59 (10), 891-896 1997

  • Pharmaceutical composition containing 2-amino-6-chloropurine-9-β-D-2', 3'-dideoxyribofuranoxside
    E Kojima, H Yoshioka, K Murakami, H Mitsuya, T Shirasaka, S Broder
    US Patent 5,580,860 1996

  • Stability of HIV-1 RNA in blood samples from patients with HIV-1 infection as determined by a quantitative polymerase chain reaction-based assay.
    T Shirasaka, E Kojima, H Mitsuya
    Clinical and diagnostic virology 7 (2), 121-124 1996

  • 2', 3'-dideoxy purine nucleosides and process for the preparation thereof
    E Kojima, H Yoshioka, H Fukinbara, K Murakami
    US Patent 5,563,049 1996

  • Synthesis and antiviral evaluation of 2, 6-diamino-9-(Np-toluenesulfonyl-pyrrolidinyl-2-methyl) purine
    E Kojima, S Miyawaki, Y Fujii, K Murakami
    Nucleic Acids Symposium Series, 233-234 1996

  • Novel purine derivatives and their anti-HIV activities
    E Kojima, S Miyawaki, M Machida, K Murakami
    Nucleic Acids Symposium Series, 231-232 1996

  • Structure-activity relationships among purines having arylsulfonyl moiety
    S Miyawaki, E Kojima, Y Fujii, K Murakami
    Nucleic Acids Symposium Series, 11-12 1996

  • Synthesis and ADA-affinity of adenine-N9-analogues
    S Miyawaki, E Kojima, K Tsuda, K Murakami
    Nucleic Acids Symposium Series, 49-50 1996

  • Quantification of viral load in patients with HIV-1 infection receiving combination chemotherapy of AZT with ddI
    E Kojima, T Shirasaka, R Yarchoan, H Mitsuya
    Nucleic Acids Symposium Series, 251-252 1996

  • 1-(Np-toluenesulfonylpyrroridino-2-methyl) uracil and its derivatives
    E Kojima, S Miyawaki, S Ishida, K Murakami
    Nucleic Acids Symposium Series, 41-42 1996

MOST CITED SCHOLAR PUBLICATIONS

  • Emergence of human immunodeficiency virus type 1 variants with resistance to multiple dideoxynucleosides in patients receiving therapy with dideoxynucleosides.
    T Shirasaka, MF Kavlick, T Ueno, WY Gao, E Kojima, ML Alcaide, ...
    Proceedings of the National Academy of Sciences 92 (6), 2398-2402 1995
    Citations: 482

  • Changes in drug sensitivity of human immunodeficiency virus type 1 during therapy with azidothymidine, dideoxycytidine, and dideoxyinosine: an in vitro comparative study.
    T Shirasaka, R Yarchoan, MC O'Brien, RN Husson, BD Anderson, ...
    Proceedings of the National Academy of Sciences 90 (2), 562-566 1993
    Citations: 163

  • Genotypic and phenotypic characterization of HIV-1 isolated from patients receiving (−)-2′, 3′-dideoxy-3′-thiacytidine
    MF Kavlick, T Shirasaka, E Kojima, JM Pluda, F Hui Jr, R Yarchoan, ...
    Antiviral research 28 (2), 133-146 1995
    Citations: 103

  • Vertical transmission of human immunodeficiency virus type 1: autologous neutralizing antibody, virus load, and virus phenotype
    RN Husson, Y Lan, E Kojima, D Venzon, H Mitsuya, K McIntosh
    The Journal of pediatrics 126 (6), 865-871 1995
    Citations: 72

  • Lipophilic halogenated congeners of 2', 3'-dideoxypurine nucleosides active against human immunodeficiency virus in vitro.
    T Shirasaka, K Murakami, H Ford Jr, JA Kelley, H Yoshioka, E Kojima, ...
    Proceedings of the National Academy of Sciences 87 (23), 9426-9430 1990
    Citations: 67

  • Escherichia coli mediated biosynthesis and in vitro anti-HIV activity of lipophilic 6-halo-2', 3'-dideoxypurine nucleosides
    K Murakami, T Shirasaka, H Yoshioka, E Kojima, S Aoki, H Ford Jr, ...
    Journal of medicinal chemistry 34 (5), 1606-1612 1991
    Citations: 53

  • Diastereo-and enantioselective reduction of α, β-diketodithiane with the baker's yeast
    T Fujisawa, E Kojima, T Itoh, T Sato
    Tetrahedron letters 26 (49), 6089-6092 1985
    Citations: 49

  • 2', 3'-dideoxy purine nucleoside
    E Kojima, H Yoshioka, H Fukinbara, K Murakami
    US Patent 5,053,499 1991
    Citations: 43

  • NP-06: a novel anti-human immunodeficiency virus polypeptide produced by a Streptomyces species
    S Chokekijchai, E Kojima, S Anderson, M Nomizu, M Tanaka, M Machida, ...
    Antimicrobial agents and chemotherapy 39 (10), 2345-2347 1995
    Citations: 41

  • Human Immunodeficiency Virus Type 1 (HIV-l) Viremia Changes and Development of Drug-Related Mutations in Patients with Symptomatic HIV-l Infection Receiving Alternating or
    E Kojima, T Shirasaka, BD Anderson, S Chokekijchai, SM Steinberg, ...
    Journal of Infectious Diseases 171 (5), 1152-1158 1995
    Citations: 40

  • A C2 Symmetry-Based HIV Protease Inhibitor, A77003, Irreversibly Inhibits Infectivity of HIV-1 In Vitro
    S KAGEYAMA, DT HOEKZEMA, Y MURAKAWA, E KOJIMA, ...
    AIDS research and human retroviruses 10 (6), 735-743 1994
    Citations: 33

  • 2', 3'-dideoxy purine nucleosides and process for the preparation thereof
    E Kojima, H Yoshioka, H Fukinbara, K Murakami
    US Patent 5,563,049 1996
    Citations: 25

  • Monitoring the activity of antiviral therapy for HIV infection using a polymerase chain reaction method coupled with reverse transcription.
    E Kojima, T Shirasaka, B Anderson, S Chokekijchai, S Sei, R Yarchoan, ...
    AIDS (London, England) 7, S101-5 1993
    Citations: 21

  • (2S,3S)-1-Phenylthio-2,3-butanediol. A Useful Chiral Building Block for a Simple Syntheses of (4R,5S)-5-Hydroxyhexan-4-olide and (4R,5S)-5-Hydroxy-2
    T Fujisawa, E Kojima, T Sato
    Chemistry Letters 16 (11), 2227-2228 1987
    Citations: 17

  • Emergence of HIV-1 variants with resistance to multiple dideoxynucleosides in patients receiving therapy with dideoxynucleosides
    T Shirasaka, M Kavlick, T Ueno, WY Gao, E Kojima, ML Alcaide, ...
    Proc Natl Acad Sci USA 92 (2398), 402 1995
    Citations: 12

  • Lipophilic 6-halo-2′, 3′-dideoxypurine nucleosides: potential antiretroviral agents targeting HIV-associated neurologic disorders
    T Shirasaka, K Watanabe, H Yoshioka, E Kojima, S Aoki, K Murakami, ...
    Advances in molecular biology and targeted treatment for AIDS, 323-333 1991
    Citations: 9

  • Identification of drug-related genotypic changes in HIV-1 from serum using the selective polymerase chain reaction
    BD Anderson, T Shirasaka, E Kojima, R Yarchoan, H Mitsuya
    Antiviral research 25 (3-4), 245-258 1994
    Citations: 8

  • ENANTIOSELECTIVE SYNTHESIS OF α-HYDROXYTHIOACETALS BY THE BAKER’S YEAST REDUCTION OF α-KETOTHIOACETALS
    T Fujisawa, E Kojima, T Itoh, T Sato
    Chemistry letters 14 (11), 1751-1754 1985
    Citations: 8

  • Antiviral effects of 6-chloro-2', 3'-dideoxyguanosine in rhesus monkeys acutely infected with simian immunodeficiency virus.
    Y Fujii, R Mukai, H Akari, M Machida, K Mori, M Takasaka, E Kojima, ...
    Antiviral chemistry & chemotherapy 9 (1), 85-92 1998
    Citations: 7

  • Efficacy of 6-chloro-2', 3'-dideoxyguanosine (6-Cl-ddG) on rhesus macaque monkeys chronically infected with simian immunodeficiency virus (SIVmac239)
    Y Fujii, R Mukai, K Mori, H Akari, I Otani, F Ono, E Kojima, M Takasaka, ...
    JAIDS Journal of Acquired Immune Deficiency Syndromes 16 (5), 313-317 1997
    Citations: 7